Report cards › Food › Sovos Brands Intermediate, Inc.
RAO'S
CSWH grade B (84)
Method v1.0 (how we grade), based on the records below; exact score 84.
| Indicator | Grade | What we found |
|---|---|---|
| Recalls (40%) | C (60) | 1 Class I (10 points) · 1 event For current recalls see FDA and USDA. |
| Ingredients (40%) | A (100) | Tier A: 0 of 67 products · A (100) (25%) Tier B: 0 of 67 products · A (100) (15%) |
| FDA warning letters (20%) | A (100) | None found to the owner Oct 29, 2021 to Oct 29, 2026. |
Shown, not graded: recall reasons (1 undeclared allergen) · IARC notes (0 products) · FDA dye pledge: none on FDA's tracker.
Recalls, Oct 29, 2021 to Oct 29, 2026
Class I, Jan 27, 2023 · Undeclared allergen · FDA event 91626
Rao's Made for Home Slow Simmered Soup, labeled as Chicken & Gnocchi, Soup in 16-ounce glass jars, 6 jars per case. Shelf stable, refrigerate after opening.
- Reason (FDA's words)
- The firm has initiated a recall of Rao's Made for Home Slow Simmered Soup, labeled as Chicken & Gnocchi but containing vegetable minestrone, with an undeclared egg allergen.
- Code information
- " Batch number: 046030Z009 " Lot number: 2320 " Packer or Manufacturer Number: MDV " Best By Date: Best By 11/15/2024
- Recalling firm
- SOVOS BRANDS INTERMEDIATE, INC.
- Dates
- Recall started Jan 27, 2023; classified Mar 3, 2023
- Status
- Terminated (status reported by FDA at classification)
- How we matched it
- matched by recalling firm (name) and brand name
FDA record F-0402-2023: openFDA · Report an error
Store-brand and co-packer recalls count on a brand only when a UPC in the recall matches one of its products.
Ingredients on our watch list
None of the 67 products with an ingredient statement contains a watched ingredient.
Labels change: each row shows the date of its FoodData Central record. A brand that has changed a recipe can report it with "Report an error".
FDA warning letters to Sovos Brands Intermediate, Inc., Oct 29, 2021 to Oct 29, 2026
None found from FDA food offices.
FDA notes that later events may have changed the regulatory status of what a letter discusses.